ArticleAutoimmunity reviews2021
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.
Abstract readLetter
In one paragraph
Article in Autoimmunity reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Antiphospholipid Antibodies and COVID-19: A Systematic Review of Clinical Implications.Immunity, inflammation and disease · 2025Pooled it
- Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review.Frontiers in immunology · 2024Pooled it
- Systematic Review of Antiphospholipid Antibodies in COVID-19 Patients: Culprits or Bystanders?Current rheumatology reports · 2021Pooled it
- Effects of antiphospholipid antibodies in the severity and outcome of COVID-19.BMC infectious diseases · 2026Article
- Antiphospholipid Antibodies in Severe COVID-19: Frequency, Clinical Features, and 12-Week Follow-Up.Cureus · 2026Article
- The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.Biomedicines · 2025Article
- Persistent Lupus Anticoagulant Positivity and Long-Term Sequelae Following Mild COVID-19.Cureus · 2024Article
- Prevalence, clinical significance, and persistence of autoantibodies in COVID-19.Virology journal · 2023Article
- Molecular mimicry and autoimmunity in the time of COVID-19.Journal of autoimmunity · 2023Review
- Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity.Biomedicines · 2023Article
- Assessment of COVID -19 associated coagulopathy and multiple hemostatic markers: a single center study in Egypt.Infection · 2023Article
- COVID-19 and the antiphospholipid syndrome.Autoimmunity reviews · 2022Review
- COVID-19 and antiphospholipid antibodies.Best practice & research. Clinical haematology · 2022Review
- Platelet Dysregulation in the Pathobiology of COVID-19.Hamostaseologie · 2022Review
- Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy.International journal of molecular sciences · 2022Review
- Evaluation of the Association between Antiphospholipid Antibodies and ICU Admission Outcome in Critically Ill COVID-19 Patients in Iranian Population.International journal of preventive medicine · 2022Article
- Risk of Thrombosis, Pregnancy Morbidity or Death in Antiphospholipid Syndrome.Frontiers in cardiovascular medicine · 2022Review
- Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia.The Pan African medical journal · 2022Article
- Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.PLoS pathogens · 2021Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Olivier VollmerService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Charles TacquardService d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Yannick DieudonnéService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Benoit NespolaLaboratoire d'Immunobiologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Laurent SattlerLaboratoire d'Hématologie, Unité d'Hémostase, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Lélia GrunebaumLaboratoire d'Hématologie, Unité d'Hémostase, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Vincent GiesService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Mirjana RadosavljevicLaboratoire d'Immunobiologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Charlotte KaeufferService de Maladies Infectieuses et Tropicales-Médecine Interne, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Yves HansmannService de Maladies Infectieuses et Tropicales-Médecine Interne, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Jean-Christophe WeberService de Médecine Interne, Hôpitaux Universitaires de Strasbourg, France.
Thierry MartinService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Laurent ArnaudService de Rhumatologie, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Olivier MorelPôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, France.
Aurélien GuffroyService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Olivier CollangeService d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Paul Michel MertesService d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Anne-Sophie KorganowService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France.
Xavier DelabrancheService d'Anesthésie-Réanimation, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Vincent PoindronService d'Immunologie Clinique-Médecine Interne, Centre National de Référence des Maladies Auto-immunes et Systémiques Rares Est/Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, France. Electronic address: vincent.poindron@chru-strasbourg.fr.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antiphospholipid SyndromeCOVID-19Antibodies, AnticardiolipinAntibodies, AntiphospholipidFollow-Up StudiesHumansLupus Coagulation InhibitorSARS-CoV-2Antibodies, AnticardiolipinAntibodies, AntiphospholipidLupus Coagulation InhibitorAnti-phospholipid antibodiesAPSCOVID-19Lupus anticoagulantSARS-CoV-2Thrombosis
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.